a neolactoside IV3- α- [Gal- β- (1→3)- GalNAc],IV2- α- Fuc- nLc4Cer(d20:1(4E))
|
UniProt
|
β- D- Gal- (1→3)- α- D- GalNAc- (1→3)- [α- L- Fuc- (1→2)]- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- β- D- Gal- (1→4)- β- D- Glc- (1↔1ʼ)- Cer(d20:1(4E))
|
SUBMITTER
|
β- D- galactosyl- (1→3)- N- acetyl- α- D- galactosaminyl- (1→3)- [α- L- fucosyl- (1→2)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1ʼ)- N- acyl- eicosasphing- 4- enine
|
SUBMITTER
|
β- D- galactosyl- (1→3)- N- acetyl- α- D- galactosaminyl- (1→3)- [α- L- fucosyl- (1→2)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1ʼ)- N- acyl- icosasphingosine
|
SUBMITTER
|
blood antigen group type II galactosyl-A(d20:1(4E))
|
SUBMITTER
|